USPatentGranted
E1

Trace elements

Granted 22 Jun 2010 · 2 office actions

Application
12/353,504
filed 14 Jan 2009
Publication
Not published
not published
Patent· this page
US RE41390
granted 22 Jun 2010

Life of the patent

2 dated events
⤢ drag to zoomJan 2009Apr 2009Jul 2009Oct 2009Jan 2010Apr 2010Jul 2010Prosecution
Prosecutionhover for detail · click to open

Abstract

A method of preparing a trace element solution includes the steps of providing at least one EDTA-complex, providing a sodium selenite solution, and combining the EDTA-complex(es) and the sodium selenite solution to form a trace element solution. A EDTA complex is prepared by using disodium EDTA or EDTA acid, selenium, and any other suitable mineral.

Description

12 parts
›The invention discloses a method of preparing a…

The invention discloses a method of preparing a trace element solution, which includes the steps of providing at least one EDTA-complex; of providing a sodium selenite solution; and of combining the EDTA-complex(es) and the sodium selenite solution. The invention further discloses at least one EDTA complex prepared by using disodium EDTA or EDTA acid; selenium; and any other suitable mineral.

›FIELD OF INVENTION

The present invention relates to trace elements.

›BACKGROUND TO INVENTION

It has been found that there is a deficiency of certain trace elements in pastures for livestock in particular areas in South Africa and also in other countries. Various suggestions have been made to provide the required trace elements to such animals. Different chemical compounds and complexes have been investigated for applying the trace elements by way of licks, drenches or injections.

In general the problem with injectable solutions is that there are too low concentrations of the minerals in the solutions. This means that relatively large quantities have to be injected, which in turn cause tissue damage and also abscesses at the site of injection. Furthermore, it is generally the case that different trace elements seldomly are individually sufficient. This means that two or more trace element solutions have to be provided by way of separate injections.

U.S. Pat. No. 4,335,116 (Howard) discloses mineral-containing therapeutic compositions containing EDTA complexes of trace elements. Notably, U.S. Pat. No. 4,335,116 utilises tetra-sodium EDTA, a selenium glycine complex, and metal chlorides for the preparation of the EDTA complexes. Unfortunately, the chloride ions cause contamination and each complex solution is to be made individually. Furthermore, overnight time is required for complexing and heating up afterward to speed up the process requires extra apparatus. If mixtures are required, the individual solutions are to be blocked. If various concentrations as well as compositions are to be made, it can only be done in a cumbersome way, requiring extra apparatus. A further problem may arise when mixtures of high concentration are needed. In certain cases it would be impossible to deliver them, because mixing is always accompanied by dilution.

It is an object of the invention to suggest methods and means for overcoming these problems.

In the specification and claims the expression EDTA refers to ethylene diaminotetraacetic acid (C 10 ,H 16 O 8 N 2 or (HO 2 CH 2 C) 2 NCH 2 CH 2 N-(CH 2 CO 2 H) 2 ).

›SUMMARY OF INVENTION

According to the invention, a method of preparing a trace element solution includes the steps

(a) of providing at least one EDTA-complex; (b) of providing a sodium selenite solution; and (c) of combining the EDTA-complex(es) and the sodium selenite solution.

If more than one EDTA-complex is used, these EDTA-complexes may be prepared in a single continuous process.

The EDTA-complex(es) may be prepared by using disodium EDTA or EDTA acid.

The EDTA-complex(es) may be prepared by using at least one selected from the group consisting of metal oxides, metal hydroxides and metal carbonates.

The EDTA-complex(es) may include at least one of the metal compounds selected from the group consisting of copper, manganese, zinc, molybdenum and chromium.

A trace element solution as prepared by a method as set out herein.

Also, according to the invention, a trace element solution includes

(a) at least one EDTA complex prepared by using disodium EDTA or EDTA acid; (b) selenium; and (c) any other suitable mineral.

The solution may be an injectable solution.

The solution may be a drenchable solution.

Further according to the invention a stock lick includes

(a) at least one EDTA complex prepared by using disodium EDTA or EDTA acid; (b) selenium; and (c) any other suitable mineral.

Also, according to the invention, a method of providing trace elements to animals, such as livestock includes the steps of preparing a trace element solution set out herein and of providing the solution in a suitable quantity to an animal.

›DESCRIPTION OF EXAMPLES

The invention will now be described by way of example of injectable solutions in accordance with the invention.

›Examples7
›Example 1

Di-Sodium Zinc Ethylene Diamino Tetra Acetate (C 10 H 12 O 8 N 2 ZnNa 2 ) in Water Solution

EDTA is suspended in a quantity of distilled water at 50° C. and is stirred continuously. In small proportions firstly sodium hydroxide (NaOH) and then zinc oxide (ZnO) are added in sequence. The pH of the clear solution obtained is measured and brought to 7, if necessary, by either the addition of NaOH (if acid) or EDTA (if alkaline). More distilled water is added to bring the zinc concentration to a predetermined level, and the solution is subsequently filtered.

If 25.16 g zinc oxide, 90.37 g EDTA and 24.74 g NaOH are used and the total volume is 1 liter, the zinc concentration in the solution will be 20 mg/ml.

›Example 2

Di-Sodium Manganese Ethylene Diamino Tetra Acetate (C 10 H 12 O 8 N 2 MnNa 2 ) in Water Solution

The same method as under example 1 is used with the following variation:

Manganese carbonate (MnCO 3 .xH 2 O) is used in place of zinc oxide.

If 45.45 g manganese carbonate, 106.39 g EDTA and 29.12 g NaOH are used, and the total volume is 1 liter, the manganese concentration will be 20 mg/ml.

›Example 3

Di-Sodium Copper Ethylene Diamino Tetra Acetate (C 10 H 12 O 8 N 2 CuNa 2 ) in Water Solution

The same method as under Example 1 is followed but with the following variation:

Basic copper carbonate (CuCO 3 Cu(OH) 2 .H 2 O) is used in place of the zinc oxide.

If 18.81 g basic copper carbonate, 45.99 g EDTA and 12.59 g NaOH are used, and the total volume is 1 liter, then the copper concentration in the solution will be 10 mg/ml.

›Example 4

Mono-Sodium Chromium Diamino Tetra Acetate (C 10 H 12 O 8 N 2 CrNa) in Water Solution

The same method as under Example 1 is followed, but with the following variation:

Chromium tri-chloride hexahydrate (CrCl 3 .6H 2 O) is used in the place of zinc oxide.

If 25.62 g chromium tri-chloride hexahydrate, 31.59 g EDTA and 15.38 g sodium hydroxide are used and the total is 1 liter, the chromium concentration in the solution will be 5 mg/ml.

›Example 5

Sodium Selenite (Na 2 SeO 3 .H 2 O) Solution in Water

If 12.09 g sodium selenite is used and the total volume is 1 liter, the selenium concentration in the solution will be 5 mg/ml.

›Example 6

A Mixture of the Compounds of Examples 1 to 5

The method is a combination of the above methods under Examples 1, 2, 3, 4 and 5 and takes place as follows:

1. The zinc preparation as per Example 1 is prepared. 2. To this added (in the same container) the chemicals as used for Example 2 for the preparation of the manganese compound. 3. Then the chemicals used as under Example 3 for the preparation of the copper compound are added. 4. At this stage the pH is brought to 7 as described under Example 1 above. 5. Subsequently the chemicals used as under Example 4 for the preparation of the chromium compound are added. 6. Lastly the chemicals used as under Example 5 are added. 7. Finally the total volume is adapted by the addition of distilled water. 8. Filtration takes place.

If 25.16 g zinc oxide, 45.45 g manganese carbonate, 18.81 g basic copper carbonate, 25.62 g chromium tri-chloride hexahydrate, 12.09 g sodium selenite, 274.34 g EDTA and 81.83 g NaOH are used, and if the total volume is 1 liter, then the zinc concentration will be 20 mg/ml, the manganese concentration 20 mg/ml, copper concentration 10 mg/ml, the chromium concentration 5 mg/ml and the selenium concentration 5 mg/ml.

›Example 7

Tetra Sodium Molybdenum Tri-Oxide Ethylene Diamino Tetra Acetate (C 10 H 12 O 8 N 2 MoO 3 Na 4 ) in Water Solution

Molybdenum tri-oxide (MoO 3 ) is suspended at room temperature in a quantity of water and stirred continuously. In portions in sequence firstly sodium hydroxide (NaOH) and then EDTA are added. The pH of the clear solution obtained is measured and it is brought to 7 if required, by adding either NaOH (if acid) or EDTA (if alkaline). More distilled water is added to bring the molybdenum concentration to a pre-determined value. The pH is changed to 6 by the addition of concentrated HCl. Filtration takes place.

If 60.02 g MoO 3 , 66.71 g NaOH and 121.84 g EDTA are used and if the volume is 1 liter, then the molybdenum concentration will be 40 mg/ml.

In all of the above examples the order of mixing the chemicals may be changed to some extent without any influence on the products formed.

All of the above products can be obtained as solids by evaporation of the appropriate solutions.

All of the above-mentioned chemicals may be substituted by others, provided the substitute are used in equivalent quantities. The particulars are as follows:

1. The di-sodium salt of EDTA in place of EDTA acid. 2. Basic zinc carbonate (2ZnCO 3 .3Zn(OH) 2 ) or zinc hydroxide (Zn(OH) 2 ) in place of zinc oxide. 3. Manganese hydroxide (Mn(OH) 2 ) in place of manganese carbonate. 4. Cupric hydroxide (Cu(OH) 2 ) or cupric oxide (CuO) in place of basic copper carbonate. 5. Anhydrous chromium tri-chloride (CrCl 3 ) in place of chromium tri-chloride hexahydrate. 6. Sodium molybdate (Na 2 MoO 4 ) in place of molybdenum tri-oxide.

1 of 12 part labels are ours — the grant heads the rest

Claims

7 · 1 independent · depth 3
1234567
7 granted claims

Classifications

17 codes
IPC · International Patent Classification
Section A — Human necessities
  • A23K1/175
  • A61K31/28
  • A23L/
  • A61K45/06
  • A23K/
  • A61P3/02
  • A61K33/00
  • A61F13/00
  • A61K33/04
  • A61K47/00
  • A01N25/00
  • A01N59/00
USPC · US Patent Classification
424/702424/600424/405424/422424/439

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
1.4 y
524 days filing → grant
Office actions
1
non-final + final
Responses
1
no RCE
Examiner
Humera N Sheikh
art unit 1615 · TC 1600
Citations: 3 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Chain of title

⤢ drag to zoom2023202420252026202720282029Owner 1liens, releases & corrections
TitleLienhover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Worldwide family

23 members · 11 offices
US5EP3WO1AU2BR3CA4DK1ES1MX1NZ1ZA1
this patentIP5 & PCTother officessolid = grantedhover for detail · click to open
Members
23
DOCDB simple family 25588884
Offices
11
US · EP · WO
Granted
9 of 23
grant date present
Non-English titles
7
shown as filed, never translated
›IP5 & PCT — 9 members
OfficePublicationKindPublishedFiledStatusTitle
USUS-2002068079-A1A16 Jun 200224 Aug 2001publishedTrace elements
USUS-6638539-B2B228 Oct 200324 Aug 2001grantedTrace elements
USUS-2004235945-A1A125 Nov 200428 Oct 2003publishedTrace elements
USthis patentUS-RE41390-EE122 Jun 201014 Jan 2009grantedTrace elements
USUS-8231910-B2B231 Jul 201228 Oct 2003grantedTrace elements
EPEP-1339416-A1A13 Sep 200317 Aug 2001publishedOligo-elementsfr
EPEP-1339416-A4A44 Feb 200417 Aug 2001publishedTrace elements
EPEP-1339416-B1B17 Nov 201217 Aug 2001grantedSpurenelementede
WOWO-0217933-A1A17 Mar 200217 Aug 2001publishedTrace elements
›Other offices — 14 members
OfficePublicationKindPublishedFiledStatusTitle
AUAU-7999401-AA13 Mar 200217 Aug 2001publishedTrace elements
AUAU-2001279994-B2B22 Sep 200417 Aug 2001grantedTrace elements
BRBR-0113668-AA3 Jun 200317 Aug 2001publishedOligoelementospt
BRBR-PI0113668-B1B111 Aug 201517 Aug 2001publishedProcesso de preparação de uma solução de oligoelemento e processo para fornecer oligoelementos a animaispt
BRBR-0113668-A8A86 Mar 201817 Aug 2001publishedoligoelementospt
CACA-2420766-A1A17 Mar 200217 Aug 2001publishedTrace elements
CACA-2589059-A1A17 Mar 200217 Aug 2001publishedTrace elements
CACA-2420766-CC11 Dec 200717 Aug 2001grantedTrace elements
CACA-2589059-CC4 Oct 201117 Aug 2001grantedTrace elements
DKDK-1339416-T3T318 Feb 201317 Aug 2001grantedSporelementerda
ESES-2394080-T3T317 Jan 201317 Aug 2001grantedOligoelementoses
MXMX-PA03001836-AA26 Mar 200417 Aug 2001publishedTrace elements.
NZNZ-524848-AA30 Jul 200417 Aug 2001publishedTrace elements
ZAZA-200106875-BB5 Sep 200121 Aug 2001publishedTrace elements.

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock